Navigation Links
Phase III data show significant reduction in blood glucose with investigational compound empagliflozin added to metformin or metformin plus sulfonylurea in adults with type 2 diabetes
Date:6/22/2013

e global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors in all of Boehringer Ingelheim's endeavors.

In 2012, Boehringer Ingelheim achieved net sales of about $19.1 billion (14.7 billion euro). R&D expenditure in the business area Prescription Medicines corresponds to 22.5 percent of its net sales. For more information please visit www.us.boehringer-ingelheim.com.

About Eli Lilly and Company
Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, IN, Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

About Lilly Diabetes
Lilly has been a global leader in diabetes care since 1923, when we introduced the world's first commercial insulin. Today we work to meet the diverse needs of people with diabetes through research and collaboration, a broad and growing product portfolio and a continued commitment to providing real solutions – from medicines to support programs and more – to make lives better.

For more information, visit www.lillydiabetes.com.

P-LLY
DIA568105PR

This press release contains forward-looking statements about empagliflozin* for the treatment of type 2 diabetes. It reflects Lilly's current beliefs; however, as with any such undertaking, there are substantial risks and uncertainties in the process of drug development and commercialization. There is no guarantee that future study results and patient exp
'/>"/>

SOURCE Eli Lilly and Company; Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
2. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
3. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
4. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
5. Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease
6. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
7. Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with Hypertriglyceridemia
8. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
9. Results Reported for Phase Ib Open-Label Clinical Trial for the Treatment of Depression Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™
10. Pearl Therapeutics Phase 2b Twice-Daily Dosing Data Suggest Morning and Evening Benefit of PT003 in Patients with COPD
11. Adamas Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for Arimenda™
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 4, 2015   InspireMD, Inc.  ("InspireMD" or the ... systems ("EPS"), today announced that it has entered into ... million shares of common stock and warrants to purchase ... in a public offering.  The common stock will be ... share, and each purchaser will receive a warrant to ...
(Date:3/4/2015)... Israël, 4 mars 2015 /PRNewswire/ ... (« RedHill » ou la « Société »), une ... sur les spécialités pharmaceutiques administrés ... stade clinique avancé pour les ... notamment les cancers gastro-intestinaux, a ...
(Date:3/4/2015)... -- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP ) announced today ... at the Ritz-Carlton at Laguna Niguel, California ... Arthur S. Przybyl , President and CEO, will give the ... ANI,s website at www.anipharmaceuticals.com . Mr. Przybyl,s presentation will ... available through the link through June 7, 2015. ...
Breaking Medicine Technology:InspireMD Announces Public Offering for Approximately $13.5 Million 2InspireMD Announces Public Offering for Approximately $13.5 Million 3InspireMD Announces Public Offering for Approximately $13.5 Million 4RedHill Biopharma présentera à l'événement en ligne sur VirtualInvestorConferences.com le 5 mars 2015 2RedHill Biopharma présentera à l'événement en ligne sur VirtualInvestorConferences.com le 5 mars 2015 3RedHill Biopharma présentera à l'événement en ligne sur VirtualInvestorConferences.com le 5 mars 2015 4RedHill Biopharma présentera à l'événement en ligne sur VirtualInvestorConferences.com le 5 mars 2015 5ANI Pharmaceuticals To Present At 27th Annual ROTH Conference 2
... YORK, Jan. 12, 2011 NeoStem, Inc. (NYSE Amex: ... company with operations in the U.S. and China, today announced ... present on Wednesday, January 12, 2011 at the OneMedForum 2011 ... at 11:00 AM PST. Both events will be held in ...
... InstaCare Corp. (OTC Bulletin Board:  ISCR) a ... testing products for the chronically ill, a leading ... and a leading developer of revolutionary cell phone ... company,s Board of Directors has received the initial ...
Cached Medicine Technology:NeoStem to Present at Two Investor Conferences in San Francisco on Wednesday, January 12, 2011 2NeoStem to Present at Two Investor Conferences in San Francisco on Wednesday, January 12, 2011 3InstaCare Corp. Announces 2011 Genstrip Guidance Report Penned by William Walling, CFA 2
(Date:3/4/2015)... Follow us on LinkedIn – Breast pumps ... the breast of a lactating mother through the suction mechanism, ... the baby. Breast pumps are used when direct feeding is ... mother being away from a child for a longer time ... are also used to stimulate lactation and relieve engorgement of ...
(Date:3/4/2015)... Baltimore, Maryland (PRWEB) March 04, 2015 ... from broccoli, announced today the rebrand of its SGS™ ... deliver at least 13 percent glucoraphanin, which is the ... the market. Brassica’s rebranding initiative includes a new truebroc ... reflect the new look and brand name. , ...
(Date:3/4/2015)... Whatever one's feelings about the Fifty Shades ... talking. Everyone from hard-core fans of the trilogy, to people ... who hasn't read even one of the books, is putting ... Korbabicz, the general manager of HUSH, a leading retailer of ... a very good thing. , "When the books came out ...
(Date:3/4/2015)... The defibrillators report provides insights into the growth trends ... global market is expected to grow at a CAGR ... 2019. It expects the emerging markets to provide crucial ... players in the market. , According to the report, ... the highest CAGR during the next five years. The ...
(Date:3/4/2015)... proud to announce a new probiotic lozenge which, in addition ... , Many health experts agree that introducing healthy bacteria ... can cause unwanted infections. While most people produce some level ... help of a probiotic to elevate the most crucial “good” ... S. salivarius M18 & K12 strains of “good” bacteria, the ...
Breaking Medicine News(10 mins):Health News:Increase in the Number of Nursing Mothers in the Workplace Spurs the Breast Pumps Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Increase in the Number of Nursing Mothers in the Workplace Spurs the Breast Pumps Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Brassica Protection Products Rebrands its SGS™ Brand of Glucoraphanin to truebroc™ 2Health News:Fifty Shades of Grey™ Has Canadians Talking About Sex. 2Health News:Defibrillators Market worth $12.9 Billion by 2019 with Rise in Aging Population - New Research Report by MarketsandMarkets 2Health News:Defibrillators Market worth $12.9 Billion by 2019 with Rise in Aging Population - New Research Report by MarketsandMarkets 3Health News:TheraBreath introduces a new line of probiotic lozenges that strengthen the body’s ability to fight germs 2
... Texas, Dec. 4 MiddleBrook,Pharmaceuticals, Inc. (Nasdaq: ... opened its,administrative and sales office in Westlake, Texas. ... certain personnel and functions, including,MiddleBrook,s research and development ... facility is expected to house up to 60 ...
... 4 Universal Health,Realty Income Trust (NYSE: UHT ... with the appointment of Marc D. Miller, Senior Vice,President of ... UHT,more than 13 years of experience in healthcare leadership roles. ... of the Acute Care Division,since 2007 and prior to that, ...
... Unites Leaders of Virginia, Maryland and D.C. AIDS Offices , ... Nationally, Washington, D.C. ranks first in AIDS cases. Of ... American. In an effort to increase awareness of this ... at the George Washington University brought together the ...
... NAPERVILLE, Ill., Dec. 4 NAMC members can gain access ... nationally-recognized speakers and opportunities for interaction via computer. The ... Finding and Communicating With Your Online Audience , ... audiences live? Once you,ve found them, do you know how ...
... ethics online forum , , ... Compliance and Ethics (SCCE) and the Health Care Compliance ... Social Network sites available to all compliance and ethics ... the social network sites and participate in the online ...
... Asks, "Is Mercury a Common Factor?" , ... announced last week call into question the safety of the ... administering multiple vaccines concurrently. , , ... published last week in PLOS One by investigators from the ...
Cached Medicine News:Health News:Middlebrook Pharmaceuticals Opens Administrative and Sales Office in Westlake, Texas 2Health News:Middlebrook Pharmaceuticals Opens Administrative and Sales Office in Westlake, Texas 3Health News:Middlebrook Pharmaceuticals Opens Administrative and Sales Office in Westlake, Texas 4Health News:Southern AIDS Living Quilt Raises Awareness in Washington, D.C. 2Health News:Southern AIDS Living Quilt Raises Awareness in Washington, D.C. 3Health News:New NAMC Member Service! Complimentary Webinars for NAMC Members - On Topics You Need to Know! Sign Up Today for This New and Exciting Educational Program! 2Health News:SCCE and HCCA Social Network Now Open to All Compliance and Ethics Professionals 2Health News:SCCE and HCCA Social Network Now Open to All Compliance and Ethics Professionals 3Health News:Researchers & Department of Defense Question Multiple Vaccine Administration 2
... positioned to support the efforts ... medication and other clinical errors. ... pharmacy support staff and automate ... lab specimens and medication chain-of-custody ...
... ability of medical equipment, devices and applications ... what is happening around them. It is ... positioning solution (IPS) establishes among people, things ... and time to be known accurately and ...
... developed to create physically secured rooms that ... are converted to RFID portals. These Intelli-Storeroom™ ... antennas by VerdaSee's Field Engineering experts. RFID ... that are to be tracked. The assets ...
... ability to track the movement of ... assets can be done. VerdaSee's "intellishelvess" ... Continuous cycle counting is possible with ... (RFID) technology makes this possible. VerdaSee ...
Medicine Products: